RCOR2 and breast carcinoma: We further confirmed that RCOR2 KO1 or KO2 did not inhibit human tumor growth in NSG mice orthotopically implanted with 2 million human MDA-MB-231 breast cancer cells (Supplemental Figure 1, D–H).